Aeon biopharma, inc.AEON.US Overview

US StockHealthcare

(No presentation for AEON)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

AEON Overall Performance

AEON AI Analysis & Strategy

AEON Recent Performance

-1.23%

Aeon biopharma, inc.

0.81%

Avg of Sector

-1.14%

S&P500

AEON PowerScanner

AEON Key Information

AEON Valuation Metrics

AEON Earnings Table

AEON Profile

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.